These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28416765)

  • 1. LoLoPicker: detecting low allelic-fraction variants from low-quality cancer samples.
    Carrot-Zhang J; Majewski J
    Oncotarget; 2017 Jun; 8(23):37032-37040. PubMed ID: 28416765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
    Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
    Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
    Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
    J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.
    Wang M; Escudero-Ibarz L; Moody S; Zeng N; Clipson A; Huang Y; Xue X; Grigoropoulos NF; Barrans S; Worrillow L; Forshew T; Su J; Firth A; Martin H; Jack A; Brugger K; Du MQ
    J Mol Diagn; 2015 Sep; 17(5):521-32. PubMed ID: 26165823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.
    Kato M; Nakamura H; Nagai M; Kubo T; Elzawahry A; Totoki Y; Tanabe Y; Furukawa E; Miyamoto J; Sakamoto H; Matsumoto S; Sunami K; Arai Y; Suzuki Y; Yoshida T; Tsuchihara K; Tamura K; Yamamoto N; Ichikawa H; Kohno T; Shibata T
    Genome Med; 2018 Jun; 10(1):44. PubMed ID: 29880027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Sequencing Using S1 Nuclease for Poor-Quality Formalin-Fixed, Paraffin-Embedded Tumor Specimens.
    Chun SM; Sung CO; Jeon H; Kim TI; Lee JY; Park H; Kim Y; Kim D; Jang SJ
    J Mol Diagn; 2018 Nov; 20(6):802-811. PubMed ID: 30055350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
    de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
    BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
    Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
    J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
    Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
    Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
    Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
    PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
    Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
    BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEEPOMICS FFPE, a deep neural network model, identifies DNA sequencing artifacts from formalin fixed paraffin embedded tissue with high accuracy.
    Heo DH; Kim I; Seo H; Kim SG; Kim M; Park J; Park H; Kang S; Kim J; Paik S; Hong SE
    Sci Rep; 2024 Jan; 14(1):2559. PubMed ID: 38297116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical validation of a next generation sequencing testing panel.
    Lüsebrink J; Pieper M; Tillmann RL; Brockmann M; Schildgen O; Schildgen V
    Exp Mol Pathol; 2018 Jun; 104(3):170-174. PubMed ID: 29641993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.